InflaRx NV (IFRX)
1.675
-0.04
(-2.05%)
USD |
NASDAQ |
Jun 09, 15:19
InflaRx EPS Diluted (Quarterly) : -0.0905 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | -2.461 |
| Immatics NV | -0.5023 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.543M |
| Total Expenses (Quarterly) | 6.543M |
| Enterprise Value | 78.71M |
| Earnings Yield | -40.68% |
| Normalized Earnings Yield | -39.13 |